Last10K.com

Q Biomed Inc. (QBIO) SEC Filing 10-K Annual report for the fiscal year ending Friday, November 30, 2018

SEC Filings

QBIO Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

QBIO Annual Reports

QBIO Quarterly Reports

QBIO Corporate News

QBIO Registration of Securities

Q Biomed Inc.

HISTORY TOOLS
CIK: 1596062 Ticker: QBIO
Document and Entity Information - USD ($)
12 Months Ended
Nov. 30, 2018
Feb. 26, 2019
May 31, 2018
Document and Entity Information   
Entity Registrant NameQ BIOMED INC.  
Document Type10-K  
Document Period End DateNov. 30, 2018  
Amendment Flagfalse  
Entity Central Index Key0001596062  
Current Fiscal Year End Date--11-30  
Entity Common Stock, Shares Outstanding 14,466,155 
Entity Filer CategoryNon-accelerated Filer  
Entity Current Reporting StatusYes  
Entity Voluntary FilersNo  
Entity Well-known Seasoned IssuerNo  
Document Fiscal Year Focus2018  
Document Fiscal Period FocusFY  
Entity Public Float  $ 34,809,642
Trading SymbolQBIO  
Entity Small Businesstrue  
Entity Emerging Growth Companyfalse  
Entity Shell Companyfalse  

View differences made from one year to another to evaluate Q Biomed Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Q Biomed Inc..

Continue

Assess how Q Biomed Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Q Biomed Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Q Biomed Inc. provided additional information to their SEC Filing as exhibits

Exhibit 31: Rule 13A-14(A)/15D-14(A) Certification
Exhibit 32: Section 1350 Certification
Ticker: QBIO
CIK: 1596062
Form Type: 10-K Annual Report
Accession Number: 0001144204-19-012723
Submitted to the SEC: Thu Mar 07 2019 1:12:08 PM EST
Accepted by the SEC: Thu Mar 07 2019
Period: Friday, November 30, 2018
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/qbio/0001144204-19-012723.htm